These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 25492391

  • 1. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
    van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Kaye KS, Bonomo RA.
    J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
    [Abstract] [Full Text] [Related]

  • 2. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
    Brizendine KD, Richter SS, Cober ED, van Duin D.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
    [Abstract] [Full Text] [Related]

  • 3. Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
    Chiu SK, Chan MC, Huang LY, Lin YT, Lin JC, Lu PL, Siu LK, Chang FY, Yeh KM.
    PLoS One; 2017 Jan; 12(4):e0175140. PubMed ID: 28388651
    [Abstract] [Full Text] [Related]

  • 4. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P, Nieberg P, Wong-Beringer A.
    Am J Infect Control; 2015 Oct 01; 43(10):1076-80. PubMed ID: 26190386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.
    Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, van Duin D, Antibacterial Resistance Leadership Group.
    Clin Microbiol Infect; 2016 Jun 01; 22(6):513-9. PubMed ID: 26850824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
    Pouch SM, Kubin CJ, Satlin MJ, Tsapepas DS, Lee JR, Dube G, Pereira MR.
    Transpl Infect Dis; 2015 Dec 01; 17(6):800-9. PubMed ID: 26341757
    [Abstract] [Full Text] [Related]

  • 9. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, Kassis I.
    J Hosp Infect; 2013 Apr 01; 83(4):307-13. PubMed ID: 23313086
    [Abstract] [Full Text] [Related]

  • 10. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
    van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans SR, Fowler VG, Bonomo RA.
    Clin Microbiol Infect; 2014 Dec 01; 20(12):O1117-20. PubMed ID: 24931918
    [Abstract] [Full Text] [Related]

  • 11. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.
    Vergadi E, Bitsori M, Maraki S, Galanakis E.
    J Pediatr Urol; 2017 Oct 01; 13(5):495.e1-495.e6. PubMed ID: 28341427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
    Mouloudi E, Massa E, Piperidou M, Papadopoulos S, Iosifidis E, Roilides I, Theodoridou T, Kydona C, Fouzas I, Imvrios G, Papanikolaou V, Gritsi-Gerogianni N.
    Transplant Proc; 2014 Nov 01; 46(9):3219-21. PubMed ID: 25420864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
    Hoxha A, Kärki T, Giambi C, Montano C, Sisto A, Bella A, D'Ancona F, Study Working Group.
    J Hosp Infect; 2016 Jan 01; 92(1):61-6. PubMed ID: 26319590
    [Abstract] [Full Text] [Related]

  • 18. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
    Bleumin D, Cohen MJ, Moranne O, Esnault VL, Benenson S, Paltiel O, Tzukert K, Mor-Yosef Levi I, Ben-Dov IZ, Levi R, Bloch A, Haviv YS.
    J Infect; 2012 Oct 01; 65(4):318-25. PubMed ID: 22722020
    [Abstract] [Full Text] [Related]

  • 19. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
    Hu Y, Ping Y, Li L, Xu H, Yan X, Dai H.
    J Infect Dev Ctries; 2016 Mar 31; 10(3):208-13. PubMed ID: 27031451
    [Abstract] [Full Text] [Related]

  • 20. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
    Su CF, Chuang C, Lin YT, Chan YJ, Lin JC, Lu PL, Huang CT, Wang JT, Chuang YC, Siu LK, Fung CP.
    Eur J Clin Microbiol Infect Dis; 2018 Apr 31; 37(4):651-659. PubMed ID: 29238934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.